TY - JOUR
T1 - Advancements in Fetal Heart Rate Monitoring
T2 - A Report on Opportunities and Strategic Initiatives for Better Intrapartum Care
AU - Lovers, Aimée
AU - Daumer, Martin
AU - Frasch, Martin G
AU - Ugwumadu, Austin
AU - Warrick, Philip
AU - Vullings, Rik
AU - Pini, Nicolò
AU - Tolladay, John
AU - Petersen, Olav Bjørn
AU - Lederer, Christian
AU - Yang, Liu
AU - Djurić, Petar M
AU - Abtahi, Farhad
AU - Holzmann, Malin
AU - Boudet, Samuel
AU - de l'Aulnoit, Agathe Houzé
AU - Georgieva, Antoniya
N1 - © 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
PY - 2025/6
Y1 - 2025/6
N2 - Cardiotocography (CTG), introduced in the 1960s, was initially expected to prevent hypoxia-related deaths and neurological injuries. However, more than five decades later, evidence supporting the evidence of intrapartum CTG in preventing neonatal and long-term childhood morbidity and mortality remains inconclusive. At the same time, shortcomings in CTG interpretation have been recognised as important contributory factors to rising caesarean section rates and missed opportunities for timely interventions. An important limitation is its high false-positive rate and poor specificity, which undermines reliably identifying foetuses at risk of hypoxia-related injuries. These shortcomings are compounded by the technology's significant intra- and interobserver variability, as well as the subjective and complex nature of fetal heart rate interpretation. However, human factors and other environmental factors are equally significant. Advancements in fetal heart rate monitoring are crucial to support clinicians in improving health outcomes for newborns and their mothers, while at the same time avoiding unnecessary operative deliveries. These limitations highlight the clinical need to enhance neonatal outcomes while minimising unnecessary interventions, such as instrumental deliveries or caesarean sections. We believe that achieving this requires a paradigm shift from subjective interpretation of complex and nonspecific fetal heart rate patterns to evidence-based, quantifiable solutions that integrate hardware, engineering and clinical perspectives. Such transformation necessitates an international, multidisciplinary effort encompassing the entire continuum of pregnancy care and the broader healthcare ecosystem, with emphasis on well-defined, actionable health outcomes. Achieving this will depend on collaborations between researchers, clinicians, medical device manufacturers and other relevant stakeholders. This expert review paper outlines the most relevant and promising directions for research and strategic initiatives to address current challenges in fetal heart rate monitoring. Key themes include advancements in computerised fetal heart rate monitoring, the application of big data and artificial intelligence, innovations in home and remote monitoring and consideration of human factors.
AB - Cardiotocography (CTG), introduced in the 1960s, was initially expected to prevent hypoxia-related deaths and neurological injuries. However, more than five decades later, evidence supporting the evidence of intrapartum CTG in preventing neonatal and long-term childhood morbidity and mortality remains inconclusive. At the same time, shortcomings in CTG interpretation have been recognised as important contributory factors to rising caesarean section rates and missed opportunities for timely interventions. An important limitation is its high false-positive rate and poor specificity, which undermines reliably identifying foetuses at risk of hypoxia-related injuries. These shortcomings are compounded by the technology's significant intra- and interobserver variability, as well as the subjective and complex nature of fetal heart rate interpretation. However, human factors and other environmental factors are equally significant. Advancements in fetal heart rate monitoring are crucial to support clinicians in improving health outcomes for newborns and their mothers, while at the same time avoiding unnecessary operative deliveries. These limitations highlight the clinical need to enhance neonatal outcomes while minimising unnecessary interventions, such as instrumental deliveries or caesarean sections. We believe that achieving this requires a paradigm shift from subjective interpretation of complex and nonspecific fetal heart rate patterns to evidence-based, quantifiable solutions that integrate hardware, engineering and clinical perspectives. Such transformation necessitates an international, multidisciplinary effort encompassing the entire continuum of pregnancy care and the broader healthcare ecosystem, with emphasis on well-defined, actionable health outcomes. Achieving this will depend on collaborations between researchers, clinicians, medical device manufacturers and other relevant stakeholders. This expert review paper outlines the most relevant and promising directions for research and strategic initiatives to address current challenges in fetal heart rate monitoring. Key themes include advancements in computerised fetal heart rate monitoring, the application of big data and artificial intelligence, innovations in home and remote monitoring and consideration of human factors.
KW - Cardiotocography/methods
KW - Cesarean Section
KW - Female
KW - Fetal Monitoring/methods
KW - Heart Rate, Fetal/physiology
KW - Humans
KW - Infant, Newborn
KW - Perinatal Care/methods
KW - Pregnancy
KW - intrapartum
KW - signal processing
KW - human factors
KW - hypoxic-ischaemic encephalopathy
KW - deep learning
KW - electronic fetal monitoring
KW - remote monitoring
KW - big data
KW - fetal (patho)physiology
KW - cardiotocography
UR - https://www.scopus.com/pages/publications/85219674585
U2 - 10.1111/1471-0528.18097
DO - 10.1111/1471-0528.18097
M3 - Journal article
C2 - 39971749
SN - 1470-0328
VL - 132
SP - 853
EP - 866
JO - BJOG : an international journal of obstetrics and gynaecology
JF - BJOG : an international journal of obstetrics and gynaecology
IS - 7
ER -